Physician-scientist-led careTrinidad & Tobago +
Exome & genome sequencing

Whole Exome Sequencing (WES)

Broad analysis of protein-coding regions across approximately 20,000 genes, guided by the clinical question and relevant medical history.

Understanding the test

Insight for a clinical question.

Whole exome sequencing examines protein-coding regions across approximately 20,000 genes to help investigate suspected inherited conditions. Interpretation can focus on a clinical presentation or selected panel areas, including neurodevelopmental, neurological, diabetes, eye, cancer and immune conditions. This breadth can be useful when several genes may explain a presentation. Ask Genomika about the analysis scope, coverage of a particular gene and the most suitable testing approach.

How it is analysed

Exome enrichment followed by next-generation sequencing and clinically directed analysis of coding-region variants.

What is included

Analysis & options.

This is an exome-wide assay rather than a fixed panel. Approximately 20,000 coding genes describes the broad assay scope; it is not a guarantee that every exon or every variant is covered. Ask for gene-specific coverage and the analysis scope.

Analysis scope

Protein-coding regions

Broad coding-region analysis across approximately 20,000 genes.

Single-nucleotide variants and small insertions/deletions

Analysis of coding-region sequence changes within the selected reportable scope.

Analysis options

Clinically focused interpretation

Panel-based interpretation for neurodevelopmental, neurological, diabetes, eye, cancer and immune presentations.

In clinical context

Understanding the scope.

Choosing a test means considering both the genes or regions examined and the types of changes it can detect.

  • Analysis focuses on protein-coding regions. Non-coding and complex structural findings may require another approach.
  • Coverage and reportability vary by gene and variant type; a negative result does not exclude an inherited condition.
  • Ask which variant classes, secondary findings and reanalysis options are included in the selected service.
  • Clinical history and the reason for testing guide interpretation and test selection.

Your next step

Discuss this test
with Genomika.

We’ll discuss the clinical question and confirm testing arrangements, sample requirements, costs and reporting times.

Enquire about this test
← Back to all tests and panels

Website privacy

Your information.

The general enquiry form prepares an email in your own email application. Form entries are not submitted to a website database or stored in your browser by this site.

If you choose to send an email, the information is handled by your email provider and received by Genomika at the displayed email address. This form is intended for general enquiries only; please do not send medical records or sensitive health information through it.

This website does not add analytics or marketing cookies. The hosting service may process technical information needed to serve the site and manage access. Please contact Genomika to discuss an appropriate route for sharing clinical information.